High-ranking OpenAI officials have been in discussions with FDA representatives about integrating AI into drug evaluation processes. Both accounts reference a project cderGPT, underscoring industry and regulatory momentum towards AI-driven reforms in healthcare, all while navigating cautious optimism and bureaucratic rigor.
Back to Top / Wednesday, May 7, 2025, 5:20 pm / permalink 4264 / 5 stories in 9 months
UK Government and OpenAI Form Strategic Partnership for AI Security / 7 months
OpenAI secures $200M defense contract deal / 8 months
DoD awards $200M AI contract to OpenAI for defense tech / 8 months
OpenAI Teams With Governments on Global AI Infrastructure / 9 months
OpenAI, Microsoft Near Consensus on Partnership Deal / 5 months
OpenAI inks historic $300B Oracle cloud deal for AI expansion / 5 months
OpenAI Backs AI-Generated Animated Film "Critterz" / 5 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.